NBY NovaBay PharmaceuticalsWatchlist
About NovaBay Pharmaceuticals Company
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
NovaBay Pharmaceuticals Partners With Woo University To Educate Eyecare Professionals On The Use Of Amniotic Membranes
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) announces its partnership with Woo University to support the education of eyecare professionals on the use of amniotic membranes. A free webinar is being held
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersAltimmune (NASDAQ:ALT) shares increased by 45.2% to $4.59 during Thursday's after-market session. The company's market cap stands at $246.6 million. NovaBay Pharmaceuticals (AMEX:NBY) stock inc
Earnings Call: NovaBay Pharmaceuticals Reports Q3 2023 Results, Product Sales Grow and Operating Loss Decreases
$Myomo(MYO.US)$ ER 5/10 AH, 1.7M license revenue.
$Quantum Computing(QUBT.US)$ participating in Cyber security event in Minneapolis on May 8-11, might have some positive news, plus ER 5/22 PM
also will add to list:
$Nemaura Medical(NMRD.US)$$Sintx Technologies(SINT.US)$